Ankerias helps clinicians and healthcare working with chronic pain identify suitable patients for spinal cord stimulation (SCS) and optimize treatment outcomes.
Built on real-world health data and AI-assisted insights, our solution supports more precise decision-making.
Ankerias helps clinicians and healthcare working with chronic pain identify suitable patients for spinal cord stimulation (SCS) and optimize treatment outcomes.
Built on real-world health data and AI-assisted insights, our solution supports more precise decision-making.
Enabling personalized spinal cord stimulation (SCS) therapy for patients with chronic pain
Enabling personalized spinal cord stimulation (SCS) therapy for patient with chronic pain
Global chronic pain
Everyone deserves to live a healthy and pain-free life. Around 1.5 billion individuals globally suffer from chronic pain, with neuropathic pain affecting 7–10% of these cases. Too many are left in pain without adequate care, leading to ongoing suffering.
Spinal cord stimulation
Spinal cord stimulation (SCS) provides pain relief when other treatments don’t. SCS reduces pain in 40–80% of treated cases. Stimulation also reduces and stabilizes drug use. Moreover, it has been shown to decrease healthcare costs by 20–50%.
However, less than 5% of eligible patients receive this treatment. Underutilization of effective care entails significant additional costs for societies in various forms.
Ankerias’s solution
Ankerias provides healthcare professionals with a digital platform that enhances the treatment of chronic pain patients. Using pain diary, data analysis, AI/ML and physiological modeling we personalize and target SCS pain therapy better.
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients do not receive this therapy early enough to achieve optimal benefit. There is a clear need for a faster, smarter tool to support patient selection and therapy optimization.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients do not receive this therapy early enough to achieve optimal benefit. There is a clear need for a faster, smarter tool to support patient selection and therapy optimization.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
After years of trying treatments that didn’t work, I was finally offered spinal cord stimulation and it changed everything. I just wish it had come earlier.
— Spinal cord stimulation patient, Oulu, Finland
Our mission is to make effective pain treatment accessible sooner for chronic pain patients. By combining AI with clinical insight, we empower healthcare professionals to make more timely and targeted decisions.
— Hanna Viisanen-Kuopila, CEO & Co-Founder, Ankerias
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients do not receive this therapy early enough to achieve optimal benefit. There is a clear need for a faster, smarter tool to support patient selection and therapy optimization.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
Spinal cord stimulation is a highly effective treatment for selected patients with chronic pain. However, identifying the right patients at the right time remains a challenge.
Many patients do not receive this therapy early enough to achieve optimal benefit. There is a clear need for a faster, smarter tool to support patient selection and therapy optimization.
— Dr. Mette Nissen, Consultant in Neurosurgery, Kuopio University Hospital
After years of trying treatments that didn’t work, I was finally offered spinal cord stimulation and it changed everything. I just wish it had come earlier.
— Spinal cord stimulation patient, Oulu, Finland
Our mission is to make effective pain treatment accessible sooner for chronic pain patients. By combining AI with clinical insight, we empower healthcare professionals to make more timely and targeted decisions.
— Hanna Viisanen-Kuopila, CEO & Co-Founder, Ankerias
Meet Team Ankerias
Meet Team Ankerias
We have a very strong background in neuroscience, pain research, data analysis, and AI/ML applications.
Hanna Viisanen-Kuopila
PhD, Adj. Prof. in Physiology
Founder, CEO
Riku Tikkanen
MSc in Computer Science
Co-founder, CTO
Our advisors
Our advisors
Mette Nissen
MD PhD, Consultant in Neurosurgery,
Kuopio University Hospital
Tapio Jakobsson
MSc, Consultant, Regulatory affairs and quality expert
Pekka Männistö
MSc, Consultant, Health economics expert
Nitin Williams
PhD, Adj. Prof. in Neuroinformatics University of Helsinki, Visiting researcher Aalto University
Alexander Helmut Jung
Associate Professor for ML,
Aalto University
Collaborators
Collaborators
Ankerias News
Follow Ankerias, progress of our project, and meet our team at forthcoming events.
Our software and processes are steadily developing and being tested during the first part of the year 2025. The first patient testing and pilot programs were planned in Q4/2024 and have been carried out in January 2025.
Drop us a message, let’s have a talk so we can tell you more about Ankerias’s solution!
Ankerias News
Follow Ankerias, our project proceedings, and meet our team at forthcoming events.
Our software and processes are steadily developing and being tested during the first part of the year 2025. The first patient testing and pilot programs were planned in Q4/2024 and have been carried out in January 2025.
Drop us a message, let’s have a talk so we can tell you more about Ankerias’s solution!
We are looking for investors and partners!
Interested to hear more? Contact us.
Ankerias is based in Espoo and Helsinki, Finland.
Let’s organize a meeting so we can look at Ankerias’s solution in detail, face to face or online.
We should discuss how we could collaborate with you and your organization!
Interested to hear more? Contact us.
Ankerias is based in Espoo and Helsinki, Finland.
Let’s organize a meeting so we can look at Ankerias’s solution in detail, face to face or online.
We should discuss how we could collaborate with you and your organization!